Kosuke Tsuji
Kosuke Tsuji has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Kouji Banno
Center of Maternal‐Fetal/Neonatal Medicine Hiroshima University Hospital Hiroshima Japan
4 shared publications - Yusuke Kobayashi
Department of Obstetrics and Gynecology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
4 shared publications - Daisuke Aoki
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan
3 shared publications - Takashi Takeda
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan
3 shared publications - Eiichiro Tominaga
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan
2 shared publications Daisuke Aoki
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan
1 shared publication
Latest Publications
- Open Access
- 9 November 2021
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 52 (2) , 128-133
Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy
Background: Microsatellite instability-high is a known biomarker for anti-PD-1/PD-L1 immune checkpoint therapy. It is also a known tumour feature of Lynch syndrome, detected most frequently in endometrial cancer. However, it remains unclear how microsatellite instability testing is carried out in the clinical field. Methods: Ninety-nine patients with gynaecological malignant tumours who underwent microsatellite instability testing as a companion diagnosis for pembrolizumab and 16 patients who previously underwent microsatellite instability testing as a screening for Lynch syndrome were recruited. Clinical information, microsatellite instability status, outcomes, genetic assessments and information about cancer tissue were retrospectively analysed. Results: Ninety-nine patients had 101 gynaecologic malignant tumours including 26 endometrial, 38 ovarian and 28 cervical cancers, 9 with other tumours including 2 synchronous endometrial and ovarian cancers. All tissue samples were successfully tested, even though some were ≥10-year-old samples. Three cases (3.0%, 3/99) showed microsatellite instability-high; all cases were endometrial cancers with one case of synchronous endometrial and ovarian cancer [11.5% (3/26) in endometrial cancer, 2.6% (1/38) in ovarian cancer], and there was no microsatellite instability-high in cervical and other cancers. One of the endometrial cancer patients received pembrolizumab treatment, but finally died of cancer. Two other cases underwent genetic testing; both were diagnosed as Lynch syndrome. Six cases (37.5%) showed microsatellite instability-high in screening for Lynch syndrome. Conclusions: Microsatellite instability-high was less commonly detected as a companion diagnosis for pembrolizumab in unselected gynaecologic patients. Genetic counselling should be always provided along with treatment selection.
- 9 November 2021
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 52 (2) , 128-133
Open AccessClinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy
Background: Microsatellite instability-high is a known biomarker for anti-PD-1/PD-L1 immune checkpoint therapy. It is also a known tumour feature of Lynch syndrome, detected most frequently in endometrial cancer. However, it remains unclear how microsatellite instability testing is carried out in the clinical field. Methods: Ninety-nine patients with gynaecological malignant tumours who underwent microsatellite instability testing as a companion diagnosis for pembrolizumab and 16 patients who previously underwent microsatellite instability testing as a screening for Lynch syndrome were recruited. Clinical information, microsatellite instability status, outcomes, genetic assessments and information about cancer tissue were retrospectively analysed. Results: Ninety-nine patients had 101 gynaecologic malignant tumours including 26 endometrial, 38 ovarian and 28 cervical cancers, 9 with other tumours including 2 synchronous endometrial and ovarian cancers. All tissue samples were successfully tested, even though some were ≥10-year-old samples. Three cases (3.0%, 3/99) showed microsatellite instability-high; all cases were endometrial cancers with one case of synchronous endometrial and ovarian cancer [11.5% (3/26) in endometrial cancer, 2.6% (1/38) in ovarian cancer], and there was no microsatellite instability-high in cervical and other cancers. One of the endometrial cancer patients received pembrolizumab treatment, but finally died of cancer. Two other cases underwent genetic testing; both were diagnosed as Lynch syndrome. Six cases (37.5%) showed microsatellite instability-high in screening for Lynch syndrome. Conclusions: Microsatellite instability-high was less commonly detected as a companion diagnosis for pembrolizumab in unselected gynaecologic patients. Genetic counselling should be always provided along with treatment selection.
- Open Access
- 22 November 2020
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 153 (3) , 398-404
Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer
Objective It is important to achieve debulking surgery to improve prognosis in ovarian cancer. Intestinal resection is adopted if the cancer is invaded and resectable; however, the preoperative evaluation method of intestinal invasion is still controversial. We conducted this research to optimize prediction for intestinal invasion of epithelial ovarian cancer. Methods Patients (n=174) who underwent primary debulking surgery for epithelial ovarian cancer were recruited for retrospective study. 28 and 146 patients were classified into the invasion and non‐invasion group, whether they needed intestinal resection or not. We collected clinical data including evaluation of CT, MRI, and barium contrast radiography and analyzed their accuracy. Results The sensitivity and specificity for intestinal invasion were 33.3 and 98.6, 42.9 and 98.6, and 66.7 and 93.9 in CT, MRI, and barium contrast radiography, respectively. CT and MRI combined showed a sensitivity of 58.3% and specificity of 96.9%; all three methods combined was the most sensitive combination showing a sensitivity of 79.2% and specificity of 90.8%. Conclusion Combination of CT, MRI, and barium contrast radiography predicts intestinal invasion with the highest sensitivity. These three modalities, however, could not predict all intestinal invasion. Patients should be informed of the possibility of unexpected extensive resection.
- 22 November 2020
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 153 (3) , 398-404
Open AccessEvaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer
Objective It is important to achieve debulking surgery to improve prognosis in ovarian cancer. Intestinal resection is adopted if the cancer is invaded and resectable; however, the preoperative evaluation method of intestinal invasion is still controversial. We conducted this research to optimize prediction for intestinal invasion of epithelial ovarian cancer. Methods Patients (n=174) who underwent primary debulking surgery for epithelial ovarian cancer were recruited for retrospective study. 28 and 146 patients were classified into the invasion and non‐invasion group, whether they needed intestinal resection or not. We collected clinical data including evaluation of CT, MRI, and barium contrast radiography and analyzed their accuracy. Results The sensitivity and specificity for intestinal invasion were 33.3 and 98.6, 42.9 and 98.6, and 66.7 and 93.9 in CT, MRI, and barium contrast radiography, respectively. CT and MRI combined showed a sensitivity of 58.3% and specificity of 96.9%; all three methods combined was the most sensitive combination showing a sensitivity of 79.2% and specificity of 90.8%. Conclusion Combination of CT, MRI, and barium contrast radiography predicts intestinal invasion with the highest sensitivity. These three modalities, however, could not predict all intestinal invasion. Patients should be informed of the possibility of unexpected extensive resection.
- Open Access
- 30 April 2019
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2019, 1-4
Laparoscopic Surgery for Ovarian Cyst Infection with Avoidance of Ureteral Injury and Uterine Perforation following Intrauterine Insemination after Abdominal Modified Radical Trachelectomy
Pelvic inflammatory disease (PID) sometimes develops after intrauterine insemination (IUI). We herein present a case of PID which developed after IUI performed after abdominal modified radical trachelectomy (AmRT) and was treated with laparoscopic surgery. To our knowledge, this is the first case report of laparoscopic surgery for PID that occurred after AmRT in Japan. A 39-year-old woman who was diagnosed with cervical cancer stage IA1 with lymphovascular invasion underwent AmRT and pelvic lymphadenectomy. At 3 years and 6 months after the surgery, she had fever and pain in her left lower abdomen 10 days after IUI. She was diagnosed with PID with left ovarian cyst infection and underwent laparoscopic left ovarian cystectomy. Before surgery, bilateral ureteral catheters were inserted because of possible difficulty identifying the ureters. During surgery, severe adhesion was seen in the pelvic cavity. By moving the catheters manually back and forth from outside the body, we were able to identify the ureters visually. A uterine manipulator was inserted during surgery, rather than before surgery, to avoid the risk of uterine perforation. Laparoscopic surgery with ureteral catheters and a uterine manipulator can be applied safely for such cases after AmRT even when severe intraperitoneal adhesion is present.
- 30 April 2019
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2019, 1-4
Open AccessLaparoscopic Surgery for Ovarian Cyst Infection with Avoidance of Ureteral Injury and Uterine Perforation following Intrauterine Insemination after Abdominal Modified Radical Trachelectomy
Pelvic inflammatory disease (PID) sometimes develops after intrauterine insemination (IUI). We herein present a case of PID which developed after IUI performed after abdominal modified radical trachelectomy (AmRT) and was treated with laparoscopic surgery. To our knowledge, this is the first case report of laparoscopic surgery for PID that occurred after AmRT in Japan. A 39-year-old woman who was diagnosed with cervical cancer stage IA1 with lymphovascular invasion underwent AmRT and pelvic lymphadenectomy. At 3 years and 6 months after the surgery, she had fever and pain in her left lower abdomen 10 days after IUI. She was diagnosed with PID with left ovarian cyst infection and underwent laparoscopic left ovarian cystectomy. Before surgery, bilateral ureteral catheters were inserted because of possible difficulty identifying the ureters. During surgery, severe adhesion was seen in the pelvic cavity. By moving the catheters manually back and forth from outside the body, we were able to identify the ureters visually. A uterine manipulator was inserted during surgery, rather than before surgery, to avoid the risk of uterine perforation. Laparoscopic surgery with ureteral catheters and a uterine manipulator can be applied safely for such cases after AmRT even when severe intraperitoneal adhesion is present.
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 29 (3) , e29
Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
Takeda T, et al. J Gynecol Oncol. 2017 Dec;29:e29. https://doi.org/10.3802/jgo.2018.29.e29
- 1 January 2018
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 29 (3) , e29
Open AccessScreening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
Takeda T, et al. J Gynecol Oncol. 2017 Dec;29:e29. https://doi.org/10.3802/jgo.2018.29.e29
- 29 August 2005
- Published by American Physical Society (APS) in Physical Review B
- Vol. 72 (6) , 060102
Pressure-induced drastic structural change in liquid CdTe
We investigate the structure of liquid CdTe at pressures up to 6 GPa by synchrotron x-ray diffraction. The structure factor, , and the pair distribution function, , change drastically within a small pressure interval of about 1 GPa (between 1.8 and 3 GPa). The , and other structural parameters, such as the average coordination number, CN, and the ratios of peak positions in or , reveal that the change originates from the pressure-induced modification in the local structure from the zinc-blende-like form into the rocksaltlike one. The liquid CdTe shows a high-pressure behavior similar to that in the crystalline counterpart in terms of the sharpness of the structural change and the high-pressure sequence in the local structure.- 29 August 2005
- Published by American Physical Society (APS) in Physical Review B
- Vol. 72 (6) , 060102
Pressure-induced drastic structural change in liquid CdTe
We investigate the structure of liquid CdTe at pressures up to 6 GPa by synchrotron x-ray diffraction. The structure factor, , and the pair distribution function, , change drastically within a small pressure interval of about 1 GPa (between 1.8 and 3 GPa). The , and other structural parameters, such as the average coordination number, CN, and the ratios of peak positions in or , reveal that the change originates from the pressure-induced modification in the local structure from the zinc-blende-like form into the rocksaltlike one. The liquid CdTe shows a high-pressure behavior similar to that in the crystalline counterpart in terms of the sharpness of the structural change and the high-pressure sequence in the local structure.